Showing results (61-70 of 142) with videos related to
Sort By:
Pageof 15
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|December 30, 2011
A randomized trial of budiodarone in paroxysmal atrial fibrillationMichael D Ezekowitz, Rangadham Nagarakanti, Andrzej Lubinski, et al.Journal of the American College of Cardiology|October 1, 2013
The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)Paul A Reilly, Thorsten Lehr, Sebastian Haertter, et al.Circulation|October 2, 2013
Management and outcomes of major bleeding during treatment with dabigatran or warfarinAmmar Majeed, Hun-Gyu Hwang, Stuart J Connolly, et al.International Journal of Cardiology. Heart & Vasculature|October 17, 2022
Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral AnticoagulantRoy Taoutel, Michael D Ezekowitz, Usman A Chaudhry, et al.Circulation|August 7, 2016
Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy)Michael D Ezekowitz, Rangadham Nagarakanti, Herbert Noack, et al.Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 12, 2008
Identification of tissue factor in experimental aortic valve sclerosisSylvestre Marechaux, Delphine Corseaux, Andre Vincentelli, et al.The American Journal of Cardiology|December 24, 2013
Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)Paolo Verdecchia, Gianpaolo Reboldi, Giuseppe Di Pasquale, et al.International Journal of Cardiology|June 21, 2015
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trialMichela Brambatti, Harald Darius, Jonas Oldgren, et al.The American Journal of Cardiology|July 24, 2012
Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke preventionPaul D Ziegler, Taya V Glotzer, Emile G Daoud, et al.Circulation|March 1, 2012
Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudyZiad Hijazi, Jonas Oldgren, Ulrika Andersson, et al.Pageof 15